Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply

Aliment Pharmacol Ther. 2014 Oct;40(7):860-1. doi: 10.1111/apt.12931.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / prevention & control*
  • Barrett Esophagus / drug therapy*
  • Esophageal Neoplasms / prevention & control*
  • Esophagus / pathology*
  • Female
  • Humans
  • Male
  • Proton Pump Inhibitors / therapeutic use*

Substances

  • Proton Pump Inhibitors